berberine HCL sustained release
Selected indexed studies
- A potential cocrystal strategy to tailor in-vitro dissolution and improve Caco-2 permeability and oral bioavailability of berberine. (Int J Pharm, 2024) [PMID:39366529]
- Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α. (Drug Deliv, 2021) [PMID:33427515]
- Role of different subtypes of adrenoceptors in pressor responses to catecholamines released from sympathetic nerve endings. (Brain Res Bull, 1997) [PMID:8978934]
_Worker-drafted node — pending editorial review._
Connections
berberine HCL sustained release helps
Sources
- Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α. (2021) pubmed
- A potential cocrystal strategy to tailor in-vitro dissolution and improve Caco-2 permeability and oral bioavailability of berberine. (2024) pubmed
- Role of different subtypes of adrenoceptors in pressor responses to catecholamines released from sympathetic nerve endings. (1997) pubmed